Anxiety Disorders: Conference Sessions

MGH 50th Annual Psychopharmacology Conference

October 16–18, 2026 · Boston, MA

• LectureClinical Trials of Cannabinoids for Insomnia, Pain, Anxiety, Depression

  Jodi Gilman · Eden Evins

  Summarizes clinical trial findings on cannabinoids for insomnia, pain, anxiety and depression.

  Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSleep & Insomnia

• LectureAnxiety Disorders and Treatments

  Jerrold F. Rosenbaum

  An update on pharmacologic treatment across the anxiety disorders.

• LectureCourse and Treatment of Mood/Anxiety During Pregnancy

  Lee S. Cohen

  How mood and anxiety disorders behave during pregnancy and how to treat them safely.

  DepressionPerinatal & Women's Mental Health

• LecturePostpartum Mood and Anxiety Disorders

  Marlene P. Freeman

  Recognition and treatment of depression and anxiety in the postpartum period.

  DepressionPerinatal & Women's Mental Health

MasterPsych Psychiatry Conference 2026

October 19–22, 2026 · Newport Beach, CA

• LectureTreatment-Resistant Anxiety: Augmentation & Advanced Approaches

  Augmentation and next-step options when anxiety disorders fail to respond to standard treatment.

  Drug Interactions & Safety

• LectureAnxiety Disorders with Multiple Comorbidities and Special Populations

  A three-hour block on anxiety management complicated by comorbidity or special-population considerations.

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• WorkshopA Climate Cafe for Clinicians: Understanding and Supporting Youth Climate Distress

  Tara Chandrasekhar · Mario F. Najera · Aya Aboelghar · Shaurya Kumar Singh · Harshita Naga Krishna Sai Vullaganti

  Introduces clinicians to youth climate distress and its mental health effects, and demonstrates the climate cafe model as a supportive, community-based approach.

  Child & AdolescentPsychotherapy

• LectureTreating Anxiety and Depression in Autism: Are SSRIs Helpful?

  Roma Vasa

  Considers whether SSRIs help treat anxiety and depression in people with autism.

  Autism & Neurodevelopmental DisordersChild & AdolescentDepression

• SymposiumThe Kids FACE FEARS Pragmatic RCT of Therapist-Led vs Guided Inference-Based CBT (ICBT) for Pediatric Anxiety: Overview, Main Findings, and Secondary Outcomes

  Jonathan S. Comer · John Piacentini · Andrea Spencer · Molly Adrian

  First-look results from the Kids FACE FEARS pragmatic randomized trial comparing therapist-led versus guided internet-delivered CBT for pediatric anxiety, presented by trial leaders Jonathan Comer and John Piacentini.

  Child & AdolescentDigital Psychiatry & AIPsychotherapy

• SessionFrom Avoidance to Re-engagement: Treating Severe School Refusal Across Higher Levels of Care

  Claudia Welke · Khushbu Shah · Melissa A. Arabadjief · Gagandeep Kaur · Kalyani Samudra

  Covers treatment approaches for severe school refusal in youth across higher levels of care.

  Child & AdolescentPsychotherapy

• LectureTreating Severe School Refusal in Residential Settings

  Kalyani Samudra

  Approaches to treating severe school refusal in residential treatment settings.

  Child & Adolescent

See all 65 anxiety disorders sessions at this meeting →

NEI Fall Congress 2026

November 5–8, 2026 · Colorado Springs, CO

• SymposiumDon't You Worry Child: Practical and Evidence-Based Care of Pediatric Anxiety

  Jeffrey Robert Strawn · Katherine K. Dahlsgaard

  Recognition, assessment, and evidence-based pharmacologic and psychotherapeutic management of anxiety disorders in children and adolescents.

  Child & Adolescent

• SymposiumFrom "Anxious" to Accurate: Neurobiology, Diagnostic Clarity, and Emerging Directions in Generalized Anxiety Disorder

  Jeffrey Robert Strawn

  Sharpens the diagnosis of generalized anxiety disorder and surveys its neurobiology and emerging treatment directions.

  Neuroscience & Mechanisms

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• PosterPregabalin: A True Dual Diagnosis Medication? Perspectives from a Case of Successful Treatment with Pregabalin in a Patient with Comorbid Alcohol Use Disorder, Anxiety, and Primary Insomnia

  Lindsey d'Arnaud

  Case of pregabalin treating co-occurring AUD, anxiety and insomnia.

  Alcohol Use DisorderSleep & Insomnia

NPA 32nd Annual Psychopharmacology Update 2027

February 10–13, 2027 · Las Vegas, NV

• LecturePostpartum Mental Health: Beyond Depression

  Benicio N. Frey

  Postpartum psychiatric presentations beyond depression, including anxiety, OCD, and psychosis, and how to treat them.

  OCD & Related DisordersPerinatal & Women's Mental HealthSchizophrenia & Psychosis

• LectureThe Menopause Transition: Mood and Anxiety

  Claudio N. Soares

  Mood and anxiety symptoms during perimenopause and menopause, with hormonal and psychopharmacologic treatment options.

  DepressionPerinatal & Women's Mental Health

• LectureTreating Anxiety in Patients with Depression and Bipolar Disorder

  Mark Zimmerman

  Managing comorbid anxiety in mood disorders, where standard anxiolytic strategies can complicate treatment.

  Bipolar DisorderDepression

• LectureTreatment of Anxiety in Children and Adolescents

  Jeffrey Robert Strawn

  Evidence-based pharmacologic and psychotherapeutic treatment of pediatric anxiety disorders.

  Child & Adolescent

Substance Use Disorders: A Comprehensive Review and Update 2027

February 15–17, 2027 · Lake Buena Vista, FL

• LectureAnxiety & Mood

  Vinod Rao

  Addresses anxiety and mood disorders co-occurring with alcohol use disorder.

  Alcohol Use DisorderDepression

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• SymposiumS10 – Innovative approaches to understanding and treating anxiety disorders: from neurobiology to cutting-edge therapies

  Andre Pittig · Iiris Hovatta · David S. Baldwin · Peter Zwanzger

  Fear extinction mechanisms, genetics, next-generation anxiolytics, and digital/VR therapies for anxiety disorders.

  Digital Psychiatry & AINeuroscience & Mechanisms

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA

• LectureADHD With Comorbidities: Anxiety, Mood Disorders, Autism, and Substance Use Disorders

  Timothy E. Wilens

  Frameworks for diagnostic clarification and treatment sequencing when ADHD co-occurs with anxiety, mood disorders, autism, or substance use, balancing symptom control against misuse and destabilization risks.

  ADHDAutism & Neurodevelopmental DisordersSubstance Use Disorders

• SymposiumFirst-Line Decisions: Lifestyle Modification or Medication? Guiding Initial Care in Generalized Anxiety Disorder

  Manish Jha · Saundra Jain · Vanessa Joy Walker

  Helps clinicians decide between pharmacotherapy and CBT, mindfulness, sleep, and exercise strategies at the outset of GAD treatment based on severity, comorbidity, trauma history, and preference.

  Lifestyle & Integrative PsychiatryPsychotherapy

• SymposiumPractical Management of Autism and Co-Occurring Psychiatric Conditions

  Kristin Sohl · Jo Hughes

  Integrated framework for assessing and treating anxiety, ADHD, and mood disorders in autistic children, including evidence-based medication use, behavioral therapy, and family engagement.

  ADHDAutism & Neurodevelopmental DisordersChild & Adolescent

• SymposiumWhen Anxiety Persists: Evidence-Based Strategies and Novel Pharmacologic Options Beyond First-Line Treatment

  Rakesh Jain · Manish Jha

  Step-by-step framework for treatment-resistant anxiety after SSRI/SNRI failure, covering sequencing, psychotherapy integration, and off-label and emerging agents from gabapentinoids to glutamatergic and GABAergic options.

  Drug Pipeline & Clinical TrialsPsychotherapy

• SymposiumMasterClass: GAD Care Reimagined: Current Best Practices and the Emerging Role of Psychedelics

  Brittany Albright · Andrew Penn

  Pairs a review of current GAD standards of care with the therapeutic rationale and emerging evidence for investigational psychedelic compounds in anxiety.

  Psychedelics